Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant TNFSF11 (Denosumab Biosimilar) anticorps

Cet anticorps Souris Monoclonal détecte spécifiquement TNFSF11 (Denosumab Biosimilar) dans FACS et in vivo. Il présente une réactivité envers Humain.
N° du produit ABIN7200656

Aperçu rapide pour Recombinant TNFSF11 (Denosumab Biosimilar) anticorps (ABIN7200656)

Antigène

TNFSF11 (Denosumab Biosimilar)

Type d'anticorp

Recombinant Antibody

Fragment

Fab fragment

Reactivité

Humain

Hôte

  • 3
  • 1
Souris

Clonalité

  • 4
Monoclonal

Conjugué

  • 3
  • 1
Cet anticorp TNFSF11 (Denosumab Biosimilar) est non-conjugé

Application

  • 3
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS), In vivo Studies (in vivo)

Classe de qualité

Research Grade
  • Fonction

    Denosumab Biosimilar, Human RANKL Monoclonal Antibody

    Specificité

    The monoclonal antibody denosumab biosimilar specifically binds to the human RANKL (RANK ligand) protein.

    Attributs du produit

    Denosumab, a fully human monoclonal antibody, inhibits the RANKL (RANK ligand) protein, the primary signal for bone removal. Denosumab can be used for the treatment of osteoporosis, treatment-induced bone loss, bone metastases, multiple myeloma, and giant cell tumor of bone.

    Purification

    Protein A or G affinity column

    Pureté

    >95 % by reducing SDS-PAGE

    Stérilité

    0.2 μm filtered

    niveau d'endotoxine

    < 1 EU per 1 mg of the protein by the LAL method

    Immunogène

    The monoclonal antibody denosumab biosimilar was produced in the denosumab biosimilar CHO stable cell line.

    Isotype

    IgG2
  • Indications d'application

    ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by denosumab.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    > 3 mg/mL

    Buffer

    PBS, pH 7.4, no stabilizers or preservatives.

    Agent conservateur

    Without preservative

    Stock

    4°C,-20 °C

    Stockage commentaire

    12 months from date of receipt, -20 to -70°C as supplied. 1 month from date of receipt, 2 to 8°C as supplied.

    Date de péremption

    12 months
  • Antigène

    TNFSF11 (Denosumab Biosimilar)

    Autre désignation

    Denosumab Biosimilar

    Classe de substances

    Biosimilar
Vous êtes ici:
Chat with us!